Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

NUWELLIS Aktie

>NUWELLIS Performance
1 Woche: 0%
1 Monat: 0%
3 Monate: 0%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>NUWELLIS Aktie
Name:  NUWELLIS INC. DL -,0001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US67113Y6032 / A40HCA
Symbol/ Ticker:  22S (Frankfurt) / NUWE (NASDAQ)
Kürzel:  FRA:22S, ETR:22S, 22S:GR, NASDAQ:NUWE
Index:  -
Webseite:  https://www.nuwellis.com/
Marktkapitalisierung:  -
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  2.5% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / 0.49 / -
Gewinnm./ Eigenkapitalr.:  -112.09% / -440.77%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  NUWELLIS
Letzte Datenerhebung:  05.07.25
>NUWELLIS Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: 0.03%
Instit. Eigner: 3.16%
>NUWELLIS Peer Group

 
04.07.25 - 20:06
XFRA: Deletion of Instruments from Boerse Frankfurt - 04.07.2025 (XETRA)
 
The following instruments on Boerse Frankfurt do have their last trading day on 04.07.2025 Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 04.07.2025 ISIN Name CA0203981034 ALMONTY INDUSTRIES INC. CNE1000062P8 BYD CO. LTD. H YC 1 FR001400RKU0 SAFE S.A. EO 0,0048 KYG9830T1224 XIAOMI CORP.B DL-,0000025 LU0396314667 ABRDNI-LATAM EQU. AAEO NO0013460071 CONSTELLATION OIL SVS.NDR US51509P1030 LANDSEA HOMES CORP. O.N. US56804T3041 MARIN SOFTWARE DL -,001 US67113Y6032 NUWELLIS INC. DL -,0001 XS2112973107 CHEPLAPHARM REGS 20/27 XS2357307664 PUNCH FIN. 21/26 REGS...
04.07.25 - 16:42
XFRA: ISIN Change (XETRA)
 
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US67113Y6032 Nuwellis Inc. 04.07.2025 US67113Y7022 Nuwellis Inc. 07.07.2025 Tausch 42:1 FR001400RKU0 SAFE S.A. 04.07.2025 FR001400ZU25 SAFE S.A. 07.07.2025 Tausch 1000:1 NO0013460071 Constellation Oil Services Holding S.A. 04.07.2025 NO0013597419 Constellation Oil Services Holding S.A. 07.07.2025 Tausch 18:1 CA0203981034 Almonty Industries Inc. 04.07.2025 CA0203987072 Almonty Industries Inc. 07.07.2025 Tausch 3:2...
02.07.25 - 14:54
Nuwellis appoints John Erb as CEO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.07.25 - 14:18
Nuwellis Appoints John Erb as Chief Executive Officer (GlobeNewswire EN)
 
Nuwellis Announces Appointment of John Erb as Chief Executive Officer...
10.06.25 - 22:18
Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option (GlobeNewswire EN)
 
MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 49,999,995 shares of Common Stock and Series B Warrants to purchase up to 16,666,665 shares of Common Stock with gross proceeds of approximately $5.0 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrants....
09.06.25 - 18:12
Nuwellis prices public offering of stock and warrants; shares down over 37% (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.25 - 15:18
Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering (GlobeNewswire EN)
 
MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the pricing of a public offering of 406,755 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 43,478,259 shares of Common Stock and Series B Warrants to purchase up to 14,492,753 shares of Common Stock....
13.05.25 - 16:00
Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
 
Nuwellis (NUWE) delivered earnings and revenue surprises of -53.33% and 23.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
13.05.25 - 13:18
Nuwellis GAAP EPS of -$0.69 misses by $0.24, revenue of $1.9M misses by $0.6M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.05.25 - 13:03
Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire EN)
 
MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced financial results for the first quarter ended March 31, 2025, and provided a business update....
12.05.25 - 20:33
Nuwellis Q1 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.05.25 - 13:03
Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency (GlobeNewswire EN)
 
Strategic agreement is expected to reduce costs, preserve expertise, and streamline operations....
08.05.25 - 13:03
Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems (GlobeNewswire EN)
 
The Company has 47 Pediatric Centers utilizing Aquadex The Company has 47 Pediatric Centers utilizing Aquadex...
24.04.25 - 13:03
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision (GlobeNewswire EN)
 
MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced the issuance of U.S. Patent No. 12,280,007 by the U.S. Patent and Trademark Office. The newly granted patent covers a fluid bag design that passively drains once full—reducing the need for manual intervention by clinical staff while preserving the system's precise weight-based measurement....
22.04.25 - 22:06
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire EN)
 
MINNEAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter 2025 on May 13, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update....
11.03.25 - 16:30
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised) (Zacks)
 
Nuwellis (NUWE) delivered earnings and revenue surprises of -51.16% and -7.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
11.03.25 - 15:45
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
 
Nuwellis (NUWE) delivered earnings and revenue surprises of 46.51% and 7.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
11.03.25 - 13:06
Nuwellis GAAP EPS of -$0.44 misses by $0.01, revenue of $2.32M misses by $0.14M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.03.25 - 13:03
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire EN)
 
MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the fourth quarter and full year ended December 31, 2024....
10.03.25 - 18:15
Nuwellis Q4 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!